Subtle inflammation: a possible mechanism of future cardiovascular risk in obese children

Watchareewan Sontichai1, Prapai Dejkhamron1, Peraphan Pothacharoen2

  • 1Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Insights

Metabolic syndrome (MetS) is common in obese Thai children, with many showing elevated inflammation markers like hs-CRP. This suggests a future cardiovascular disease risk, even without MetS.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Disease Risk Factors
  • Metabolic Syndrome Research

Background:

  • Systemic inflammation is linked to cardiovascular disease (CVD) in obese adults with metabolic syndrome (MetS).
  • Understanding MetS and inflammation in obese children is crucial for early CVD risk assessment.

Purpose of the Study:

  • To determine the prevalence of MetS in obese Thai children.
  • To investigate the relationship between MetS and inflammatory markers in this population.

Main Methods:

  • A cross-sectional study involving 58 obese Thai children.
  • Assessed fasting blood glucose, oral glucose tolerance, insulin, lipid profiles, and inflammatory markers (IL-6, TNF-α, hs-CRP).
  • Excluded children with specific health conditions or recent illnesses.

Main Results:

  • Prevalence of MetS was 31% and prediabetes was 17.2% among obese Thai children.
  • Children with MetS showed higher insulin resistance but similar glucose and lipid profiles compared to those without MetS.
  • Elevated high-sensitivity C-reactive protein (hs-CRP) was observed in 69% of participants, irrespective of MetS status.

Conclusions:

  • Obese Thai children exhibit a significant prevalence of MetS.
  • Widespread elevated hs-CRP indicates ongoing inflammation, potentially increasing future CVD risk in all obese children, not just those with MetS.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Inflammation01:38

Inflammation

Overview
62.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
590
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
459